Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Cancer Cytopathol. 2021 Nov 30;130(4):284–293. doi: 10.1002/cncy.22537

TABLE 6.

Cases With Histologic Follow-Up and Correlation With Indeterminate Cytology

Variable FN (n = 34) FLUS (n = 35) OR P
Age, range, y 17–79 20–74
Sex, No.
 Female 30 26
 Male 4 9
Molecular alterations, No.
 RAS alone 13 23 0.33 .02
 RAS with others 21 12
Procedure, No.
 Lobectomy 15 22 0.47 .09
 Total 19 13
Histology, No.
 Nonneoplastic 14 19 0.3 .025a
 Neoplastic 6 10
 Malignant 14 6
Molecular alteration and histology correlation, No.
 RAS alone + negative histology 11 19 1.15 .72
 RAS alone + positive histology 2 4
 RAS and others + negative histology 9 10 0.159 .03
 RAS and others + positive histology 12 2
Risk of malignancy, %
 RAS alone 15 17 0.27 .003
 RAS with others 57 17
 RAS (overall) 38 17

Abbreviations: FLUS, follicular lesion of undetermined significance; FN, follicular neoplasm; OR, odds ratio.

a

Nonneoplastic + neoplastic versus malignant = P value.